ハイスループットスクリーニングの市場規模は2023年に211億ドルと評価され、2024年から2030年にかけて10.6%のCAGRで成長すると予測されます。多国籍企業による研究開発のための資金の増加が、臨床試験を推進し、市場の成長に貢献しています。ハイスループットスクリーニング (HTS) は、その優れた性能によって、幹細胞研究、毒物学、その他のライフサイエンス分野での使用が増えており、需要の増加と市場の成長につながっています。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. High Throughput Screening (HTS) Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. High Throughput Screening (HTS) Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. High Throughput Screening (HTS) Market: Product and Services Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. High Throughput Screening (HTS) Market: Product and services Movement Analysis, 2023 & 2030 (USD Billion)
4.3. Consumables
4.3.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.3.1.1. Reagents & Assay Kits
4.3.1.1.1. Reagents & Assay Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.3.1.2. Laboratory Equipment
4.3.1.2.1. Laboratory Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4. Instruments
4.4.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4.1.1. Liquid Handling Systems
4.4.1.1.1. Liquid Handling Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4.1.2. Detection Systems
4.4.1.2.1. Detection Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4.1.3. Other Instruments
4.4.1.3.1. Other Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.5. Services
4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.6. Software
4.6.1. Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. High Throughput Screening (HTS) Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. High Throughput Screening (HTS) Market: Technology Movement Analysis, 2023 & 2030 (USD Billion)
5.3. Cell-based Assays
5.3.1. Cell-based Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.1.1. Fluorometric Imaging Plate Reader Assays
5.3.1.1.1. Fluorometric Imaging Plate Reader Assays Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.1.1.2. Clinical Applications
5.3.1.1.2.1. Clinical Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.1.1.3. In-vitro Studies
5.3.1.1.3.1. In-vitro Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.1.2. Reporter Based Assays
5.3.1.2.1. Clinical Applications
5.3.1.2.1.1. Clinical Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.1.2.2. In-vitro Studies
5.3.1.2.2.1. In-vitro Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.1.3. 3D - Cell Cultures
5.3.1.3.1. 3D - Cell Cultures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.1.3.2. Scaffold-based Technology
5.3.1.3.2.1. Scaffold-based Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.1.3.3. Scaffold-free Technology
5.3.1.3.3.1. Scaffold-free Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.1.4. 2D - Cell Cultures
5.3.1.4.1. 2D - Cell Cultures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.1.5. Reporter-based Assays
5.3.1.5.1. Reporter-based Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.1.6. Perfusion Cell Culture
5.3.1.6.1. Perfusion Cell Culture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.4. Lab-on-a-chip Technology (LOC)
5.4.1. Lab-on-a-chip Technology (LOC) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.5. Label-free Technology
5.5.1. Label-free Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.6. Ultra High Throughput Screening
5.6.1. Ultra High Throughput Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 6. High Throughput Screening (HTS) Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. High Throughput Screening (HTS) Market: Application Movement Analysis, 2023 & 2030 (USD Billion)
6.3. Drug Discovery Programs
6.3.1. Drug Discovery Programs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4. Chemical Biology Programs
6.4.1. Chemical Biology Programs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.5. Biochemical Screening
6.5.1. Biochemical Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6. Cell & Organ-based Screening
6.6.1. Cell & Organ-based Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 7. High Throughput Screening (HTS) Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. High Throughput Screening (HTS) Market: End Use Movement Analysis, 2023 & 2030 (USD Billion)
7.3. Pharmaceutical & Biopharmaceutical Companies
7.3.1. Pharmaceutical & Biopharmaceutical Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4. Academic & Research Institutes
7.4.1. Academic & Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.5. Contract Research Organizations (CROs)
7.5.1. Contract Research Organizations (CROs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.6. Others
7.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 8. High Throughput Screening (HTS) Market: Regional Estimates & Trend Analysis
8.1. High Throughput Screening (HTS) Market Share, By Region, 2023 & 2030 (USD Billion)
8.2. North America
8.2.1. North America High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.2.2. U.S.
8.2.2.1. U.S. High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.2.3. Canada
8.2.3.1. Canada High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.2.4. Mexico
8.2.4.1. Mexico High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3. Europe
8.3.1. Europe High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.2. U.K.
8.3.2.1. U.K. High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.3. Germany
8.3.3.1. Germany High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.4. France
8.3.4.1. France High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.5. Italy
8.3.5.1. Italy High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.6. Spain
8.3.6.1. Spain High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.7. Denmark
8.3.7.1. Denmark High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.8. Sweden
8.3.8.1. Sweden High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.9. Norway
8.3.9.1. Norway High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4. Asia Pacific
8.4.1. Asia Pacific High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4.2. China
8.4.2.1. China High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4.3. Japan
8.4.3.1. Japan High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4.4. India
8.4.4.1. India High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4.5. South Korea
8.4.5.1. South Korea High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4.6. Australia
8.4.6.1. Australia High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4.7. Thailand
8.4.7.1. Thailand High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.5. Latin America
8.5.1. Latin America High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.5.2. Brazil
8.5.2.1. Brazil High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.5.3. Argentina
8.5.3.1. Argentina High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.6. Middle East and Africa
8.6.1. Middle East and Africa High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.6.2. Saudi Arabia
8.6.2.1. Saudi Arabia High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.6.3. UAE
8.6.3.1. UAE High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.6.4. South Africa
8.6.4.1. South Africa High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.6.5. Kuwait
8.6.5.1. Kuwait High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. Agilent Technologies, Inc.
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/ Strategic Initiatives
9.4.2. Danaher Corporation
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/ Strategic Initiatives
9.4.3. Thermo Fisher Scientific Inc.
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/ Strategic Initiatives
9.4.4. PerkinElmer Inc.
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/ Strategic Initiatives
9.4.5. Bio-Rad Laboratories, Inc
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/ Strategic Initiatives
9.4.6. Aurora Biomed Inc.
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/ Strategic Initiatives
9.4.7. Tecan Trading AG
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/ Strategic Initiatives
9.4.8. Promega Corporation
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/ Strategic Initiatives
9.4.9. Charles River Laboratories.
9.4.9.1. Participant’s Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Recent Developments/ Strategic Initiatives
9.4.10. Creative Biolabs.
9.4.10.1. Participant’s Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Recent Developments/ Strategic Initiatives